v3.26.1
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Cash flows from operating activities:      
Net income (loss) $ (8,307) $ 4,796 $ (6,500)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation of property, plant and equipment 1,421 1,649 514
SEPA commitment fees 359
Financial (income) expense related to loan from others 33 1,278 401
Revaluation of warrants (3) (93) (4,140)
Gain on troubled debt restructuring (14,759)
Share-based compensation 303 682 1,139
Decrease (increase) in trade receivables 10 (83)
Decrease (increase) in other receivables 43 224 (290)
Changes in operating lease right-of-use assets 89 284 43
Increase (decrease) in trade payables 31 (156) (150)
Changes in operating lease liabilities 147 (314) (58)
Increase (decrease) in other payables (157) 157 (341)
Net cash used in operating activities (6,031) (6,335) (9,382)
Cash flows from investing activities:      
Purchase of property, plant and equipment (24) (12) (637)
Net cash used in investing activities (24) (12) (637)
Cash flows from financing activities:      
Proceed from exercise of warrants, net   1,441 947
Proceeds from issuance of shares, net   2,000 139
Proceeds from issuance of ordinary shares for SEPA holders, net 5,770
Net cash provided by financing activities 5,770 3,441 1,086
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1 (9) (272)
Increase (decrease) in cash, cash equivalents and restricted cash (284) (2,915) (9,205)
Cash, cash equivalents and restricted cash at beginning of year 2,095 5,010 14,215
Cash, cash equivalents and restricted cash at end of year 1,811 2,095 5,010
Supplementary disclosure of cash flows activities:      
Interest 143 833
(2) Non-cash transactions:      
Recognition of right-of-use assets and lease liabilities upon exercise of lease extension option 952
Reclassification of warrants liability to equity 398
Shares issued for SEPA financing agreement 150    
Loan convert into preferred shares 5,627
Exercise of warrants liability into shares 801
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 1,661 1,964 4,870
Restricted cash 150 131 140
Cash, cash equivalents and restricted cash $ 1,811 $ 2,095 $ 5,010